琥珀酸拉米丹结构式
|
常用名 | 琥珀酸拉米丹 | 英文名 | Lasmiditan hemisuccinate |
|---|---|---|---|---|
| CAS号 | 439239-92-6 | 分子量 | 872.80900 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C42H42F6N6O8 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
琥珀酸拉米丹用途Lasmiditan, also known as COL-144 and LY573144, is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist (K1=2.21 μM) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study. Lasmiditan showed efficacy in its primary endpoint, with a 2-hour placebo-subtracted headache response of 28.8%, though with frequent reports of dizziness, paresthesias, and vertigo. |
| 中文名 | 琥珀酸拉米丹 |
|---|---|
| 英文名 | butanedioic acid,2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)pyridin-2-yl]benzamide |
| 英文别名 | 更多 |
| 分子式 | C42H42F6N6O8 |
|---|---|
| 分子量 | 872.80900 |
| 精确质量 | 872.29700 |
| PSA | 206.18000 |
| LogP | 7.13100 |
| InChIKey | MSOIHUHNGPOCTH-UHFFFAOYSA-N |
| SMILES | CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1.CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1.O=C(O)CCC(=O)O |
| 储存条件 | -20°C, 密封, 干燥 |
| Lasmiditan succinate (USAN) |
| 2,4,6-Trifluoro-N-(6-((1-methylpiperidine-4-yl)carbonyl)pyridin-2-yl)benzamide hemisuccinate |
| UNII-W64YBJ346B |
| Lasmiditan succinate |
| Lasmiditan hemisuccinate |